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IN this prospective study, a quantitative determination of
histamine and tryptase in nasal secretions after nasal
phosphate buffered saline (PBS) and allergen challenge
was performed in 18 atopic patients who were compared
with ten non-allergic healthy volunteers. The aim of the
studywas to determine the normal and pathological con-
centrations of these important mediators in nasal secre-
tions. The second objective was to test the relevance of
these two mast cell secreted mediators after nasal chal-
lenge. Results showed that the concentrations oftryptase
in almost all samples were under the minimal detection
limit (< 0.5 tU/g) and only a sigrtificant increase of
tryptase (median, 28 tU/g) occurred immediately after
nasal allergen challenge in the patient group. Histamine
concentration significantly increased after every nasal
PBS challenge (median, 69 ng/g after first PBS challenge
and 165 ng/g after second PBS challenge) in the control
group, as well as in the patient group after both PBS
(median, 69 ng/g) and allergen (median, 214 ng/g) chal-
lenge. On the other hand, a rapid onset of sneezing and
increase in nasal airway resistance was experienced only
in the patient group after nasal allergen challenge, but did
not occur after PBS challenge even though the histamine
concentrations significantly increased in both groups.
This study suggests that tryptase is a more preferable
marker than histamine in quantitative monitoring of
mast cell activation especially during the early phase
nasal allergic reaction.
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Introduction
It has been a well-established fact for many years
that histamine and tryptase are both mast cell prod-
ucts. Increases of these two components in body
fluids have been regarded as markers for mast cell
activation in allergic reactions.1- Numerous clinical
and experimental models have demonstrated that
histamine is a most important mediator during the
early-phase nasal allergic reaction.
Until now, measurable histamine levels has been
found not only in plasma and urine but also in tears,
gastric juice, blister fluid and cerebral spinal fluid.
While the published data give the normal and patho-
logical concentrations of histamine in body fluids,
the quantification of histamine in nasal secretions,
however, has not yet been well established. The
most common technique in use until now has been
nasal lavage. The drawback of this technique, how-
ever, is that the dilutional effect of nasal secretions
by lavage fluid is unknown. Therefore, the impor-
tant question regarding the exact normal and patho-
logical concentrations of histamine in nasal secre-
tions still remains unanswered.
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In this study the authors used the nasal
microsuction technique as a sampling tool for deter-
mination of histamine and tryptase levels in nasal
secretions after nasal allergen challenge (NAC). The
aim of the study was to obtain quantitative data of
these two components in nasal secretions during
allergen-induced nasal allergic reaction compared
with the baseline values. The second objective was
to test the relevance of these two markers of mast cell
activation after nasal challenge, with routine negative
control solution of PBS and allergen.
Materials and Methods
Patients: Eighteen patients (males, eleven; females,
seven) aged from 18 to 45 years (mean age, 28 years)
had nasal atopy to grass pollen confirmed by medical
history, skin test and nasal grass pollen challenge.
Eleven of the 18 patients also had atopy to house
dust and/or mites as evidenced by skin test. How-
ever, they were all symptom-free and they had a
normal nasal airway resistance (NAR) as confirmed
by passive anterior rhinomanometry (PAR). A control
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group consisted of ten healthy volunteers (males,
five; females, five) aged from 20 to 43 years (mean
age, 28 years). All of them (in both groups) had
normal findings on rhinoscopy, routine blood chem-
istry parameters and haematological examinations.
They had no disease of the respiratory tract, nor had
they taken any medication (except oral contracep-
tives) during the previous 3 months. The study was
performed 3 months after the pollen season. The
subjects gave their informed consent. This study was
approved by the local ethics committee.
The aspiration system: The authors used the
Biewenga’s aspiration system as described previ-
ously. The samples were collected by repeated aspi-
ration from the middle meatus and from the floor of
both nasal cavities, into a pre-weighed plastic sam-
piing tube. This was immediately followed by aspi-
ration of a known volume (1.0 ml) of PBS (pH 7.4)
including 10% of Mesna (Mistabron, UCB Pharma-
ceutics Company, Belgium). Mesna acts by disrupt-
ing the disulphide bonds of the mucus p.olypeptide
chains, and is necessary in order to obtain a good
quality supernatant. The amount of secretion sam-
pled was measured by weighing the collection tube
and the tube with the aliquot of PBS before and after
sampling.
Nasal challenge and samplingprocedure: Nasal chal-
lenge was carried out by using nasal aerosol appli-
cation with a Heyer nebulizer (Heyer Company,
Germany) of the control solution (sterilized PBS, pH
7.4) and grass pollen mixtures (20000 AU/ml,
HALAB Allergy Service, Belgium). The nebulizer
contained a provocation extract or the PBS. The nasal
mucosa was consecutively provoked six times during
10 s (three times for each nostril alternately), the
study subject being in complete apnoea after a full
inspiration. This precaution prevented the provoca-
tion extract from entering the bronchial tree. The
temperature of the aerosol was maintained between
28 and 30C.
First, two consecutive samples were collected in
the early morning (about 08:30 h) as a control of the
baseline values. Incidentally, this provided consider-
able data on whether an increase of mediators was
induced by the irritant action of nasal aspiration.
Fifteen min later, two consecutive nasal challenges
with PBS and allergen (PBS again for the control
group) were performed in single blind with an inter-
val of 15 min. Nasal secretions were then collected 5
min after each challenge. The samples were cooled
on ice immediately after sampling, then mixed in a
Vortex mixer, and centrifuged at 1000 xg at 4C for
15 min. The supernatants were stored at-20C until
used.
Measurement of the mediators: The mediators of
histamine and tryptase were determined by follow-
ing the instructions for radioimmunoassay (RIA, RIA
kits from Kabi Pharmacia, Sweden). For histamine,
the total coefficient of variation (% CV) was lower
than 11.9% in the working range of the assay. The
minimal detectable dose of the histamine assay was
2 ng/ml; this sensitivity was sufficient for our pur-
pose as all samples had values exceeding 7.5 ng/g.
For tryptase, the detection limit is 0.5 U/1 defined as
the concentration indicated by the counts of three
standard deviations above that of a zero sample.
Between-assay variability was lower than 5% within
the working range for our samples. To evaluate the
possible influence of Mesna, this product was added
in recovery experiments and did not show any influ-
ence on the radioimmunoassay results.
The reliability of the histamine measurement was
confirmed by an additional experiment. One sample
with a highest concentration of histamine from each
healthy volunteer and patient was selected again,
and was additionally prepared by adding the same
volume of a 2.5 mg/ml diamine oxidase (Sigma, USA)
solution. After incubation at 37C for 1 h, the hista-
mine concentration was measured again by follow-
ing the same protocol.
Objective evaluation: The number of sneezes was
recorded by absolute count. Nasal airway resistance
(NAR) was measured by PAR (Heyer Company, Ger-
many) expressed in Pa/cm3/s of the left and right
sides. A 100% increase of NAR at one or both nasal
cavities was considered as a nasal obstruction.
Statistical evaluation: All statistical tests were carried
out two-tailed at the 1% level of significance in order
to correct for multiple comparison. The calculations
were performed using the SPSS/PC+ program on an
IBM compatible microcomputer. The Wilcoxon rank
sum test was used to compare all the parameters with
baseline value after NAC.
Results
The study was performed without any complica-
tion such as asthma or epistaxis. All test subjects
could complete their tests according to the study
protocol. The amount of secretion obtained from the
normal volunteers varied between 50 and 540 mg
(median, 285 mg), and that from the patients, be-
tween 80 and 870 mg (median, 300 mg). It was of
course easier to obtain more secretion after NAC.
None of the study subjects experienced sneezing
or nasal obstruction at baseline. No significant
change occurred in the number of sneezes and in
nasal airway resistance before and after nasal PBS
challenges in the control group and in the patient
group. Sneezes were counted in 13 patients (76%)
(range, 4- 20 times) within 5 min of NAC. Seventeen
patients (94%) showed nasal obstruction. Only one
patient failed to show any response after NAC and
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was disregarded for further evaluation.
There was no significant difference in the median
values for histamine and tryptase between men and
women, or between the first two consecutive sam-
pies. But the baseline histamine concentration was
significantly higher in the patient group (median, 36
ng/g) than in the control group (median, 19 ng/g).
After adding the diamine oxidase to the samples, an
average decrease of 74.9% of histamine occurred
compared with the same samples not pre-treated
with diamine oxidase.
The control group:
Histamine. Histamine (Fig. 1) showed a median
baseline value of 19 ng/g (range, 7.5-32 ng/g). There
was a significant increase in median histamine con-
centration to 63 ng/g (range, 22-722 ng/g) after the
first PBS challenge, and 65 ng/g (range, 17-1065 ng/
g) after the second PBS challenge. An overlap existed
between the histamine values of the two consecutive
challenges and those of the baseline.
Tryptase. Tryptase (Fig. 2) showed a median base-
line value of 0 (range, 0-11.2 l.tU/g). There was a
slight increase to a median value of 1.6 ILtU/g (range,
0-35.9 ILtU/g) after the first PBS challenge, and 3.5
ILtU/g (range, 0-56.5 ILtU/g) after the second PBS
challenge, but these changes were not statistically
significant.
The patient group:
Histamine. The concentration of histamine (Fig. 3)
showed a median baseline value of 36 ng/g (range,
22-69 ng/g). A significant increase also occurred up
to a median value of 69 ng/g (range, 19-543 ng/g)
immediately after PBS (overlap) and to 214 ng/g
(range, 77-592 ng/g) after allergen challenge (no
overlap).
Tryptase. The median concentration of tryptase
(Fig. 4) at baseline was very low, i.e., 0.1 ILtU/g
(median, 0-6.9 btU/g). There was a significant in-
crease only at the median concentration to 28 l.tU/g
(range, 0-253 l.tU/g) after NAC (overlap).
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FIG. 2. Tryptase concentrations in the control group (n 10) after two
consecutive PBS nasal challenges.
An additional experiment was again performed 6
months after the first experiment in five of the six
volunteers of the control group in whom histamine
concentration significantly increased after PBS chal-
lenge. One female subject could not participate in
this confirmatory experiment due to pregnancy. In
these five volunteers, four repeated nasal samples
were obtained by microsuction at 15 min intervals,
followed by four times PBS nasal challenge also at 15
min intervals. Nasal secretions were collected imme-
diately after each challenge. The results showed that
histamine (Fig. 5) as well as tryptase levels (Fig. 6)
were not increased in the first four samples without
any challenge. Histamine showed significantly in-
creased levels after PBS nasal challenges in all the
samples (no overlapping). Tryptase, however, was
only slightly increased in a few samples (17.5%). In
this group, no statistical evaluation was performed
because of the small number of study subjects. How-
ever, there was a poor correlation between these two
mediators with respect to their responsiveness to PBS
nasal challenge.
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FIG. 1. Histamine concentrations in the control group (n 10) aRer two
consecutive PBS nasal challenges.
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FIG. 3. Histamine concentrations in the patient group (n 17) after PBS
allergen nasal challenges.
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FIG. 5. Histamine concentrations in nasal secretions of five non-allergic
healthy volunteers during four repeated nasal microsuctions without any
challenge and followed four times by nasal PBS challenge.
lOO
70 , 60
50 . ,4.0
I-- 30
2O
suction only PBS challenge
Samples
FIG. 6. Tryptase concentrations in nasal secretions of five non-allergic
healthy volunteers during four repeated nasal microsuctions without any
challenge and followed four times by nasal PBS challenge.
Discussion
In recent years, it has been clearly demonstrated
that mast cell activation and the release of inflamma-
tory mediators are the initial events in the
pathophysiology of the early phase in allergic
rhinitis. It has also been suggested that the combined
study of histamine and tryptase measurement can
therefore provide useful insight into the role of mast
cell activation in the pathogenesis of inflammatory
responses.
Until now, histamine and tryptase in nasal secre-
tions have mostly been studied by using nasal lavage
as a sampling tool. The development of nasal lavage
models for the recovery of secretions on the surface
of the nasal mucosa has also made it possible to
identi a post-allergen challenge increase in a vast
number of putative mediators of inflammation in
vivo in humans. With the lavage technique, how-
ever, it is almost impossible to determine the real
concentrations of mediators in nasal secretions
because the dilution factor cannot be correctly esti-
mated. The quantitative determination of these me-
diators is certainly important, especially when these
mediators are present in very low concentration in
nasal secretions. Therefore, precise quantitative data
regarding the changes in the mediator concentration
can give reliable information to help understand the
pathophysiology of allergic rhinitis.
By using nasal microsuction technique, the authors
were able to quantify the concentration of each
mediator in nasal secretions. It also allowed monitor-
ing of the histamine and tryptase concentration in
response to nasal provocation with different non-
allergic stimuli such as PBS and allergen. Further-
more, it has been proved that the microsuction
technique in itself does not cause any increase in
mediators.
Significantly higher histamine concentrations were
found in the patient group (median, 36 ng/g) than in
the control group (19 ng/g). A significant increase in
histamine concentration in the nasal secretions fol-
lowing PBS nasal challenge both in the patient and
in the control group has also been demonstrated,
although there existed considerable overlapping. In
the patient group, after nasal allergen challenge a
significant increase in histamine concentration oc-
curred immediately without any overlapping. These
increases correlate very well with nasal symptoms.
The reliability of the measurement of histamine has
been further confirmed by its susceptibility to
diamine oxidase treatment. Our data prove that his-
tamine can be released into the nasal secretions not
only following local allergen challenge but also after
PBS challenge. In the control group there was, how-
ever, poor correlation between the increase in hista-
mine concentrations in the nasal secretions and the
nasal symptoms with PBS only. In the extracellular
environment and in the circulation, histamine has a
half-life of less than 1 min, because of its rapid
metabolism to inactive products. Histamine is
metabolized via two pathways, namely a
diaminooxidase pathway leading to imidazole acetic
acid and a methyltransferase pathway leading to
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N-methylhistamine and N-methylimidazoleacetic
acid. 1,11 As the sensitivity of Pharmacia histamine RIA
is 18 times greater towards methylhistamine than
towards histamine, it is possible that ’histamine’ in
this study is actually reflecting a mixture of histamine
and methylhistamine.
Tryptase concentrations in almost all samples were
below the minimal detection limit (0.5 btU/g). It only
increased significantly in the nasal secretions of pa-
tients after nasal allergen challenge. These tryptase
increases correlated very well with the concomitant
histamine increases, as well as with the nasal symp-
toms. Furthermore tryptase was not significantly in-
creased after nasal PBS challenge as demonstrated
both in the allergic and the non-allergic group. If
tryptase is only a specific marker of mast cell activa-
tion, then the increase in histamine concentrations in
the nasal secretions after nasal PBS challenge cannot
be explained by mast cell activation. The authors are
not sure from where this histamine comes. As re-
ported in the literature, the synthesis and storage of
histamine mainly takes place in tissue mast cells and
in certain white blood cells, i.e., the basophilic
granulocytes. Under certain circumstances some
foods contain histamine, and histamine can also be
produced by bacterial flora. 12 Bacteria can trigger
histamine release by immunological (IgE-dependent)
and non-immunological mechanisms. 13 The mecha-
nisms of histamine production as well as the trigger
factor for the release require further study. On the
other hand, our data revealed the important fact that
PBS is not a reliable negative control solution, at least
for nasal challenge especially when an evaluation of
histamine concentration is involved.
In summary, it is obvious that the rise in histamine
concentrations can be caused not only by IgE-medi-
ated mast cell activation but also by other unknown
mechanisms. Tryptase is a more reliable marker than
histamine, both in the qualitative and quantitative
monitoring of mast cell activation, especially during
the early phase of nasal allergic reaction.
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